Long-term physical activity leads to a significant increase in serum sRAGE levels: a sign of decreased AGE-mediated inflammation due to physical activity?

Michael Sponder, Ioana-Alexandra Campean, Michael Emich, Monika Fritzer-Szekeres, Brigitte Litschauer, Senta Graf, Daniel Dalos, Jeanette Strametz-Juranek, Michael Sponder, Ioana-Alexandra Campean, Michael Emich, Monika Fritzer-Szekeres, Brigitte Litschauer, Senta Graf, Daniel Dalos, Jeanette Strametz-Juranek

Abstract

There is growing evidence that low levels of the circulating soluble receptor of advanced glycation end products (sRAGE) are a valuable predictor of cardiovascular disease (CVD). The aim of this prospective study was to investigate the influence of long-term physical activity on serum sRAGE levels. 109 subjects were recruited, and 98 completed the study. Participants were asked to perform exercise within the calculated training pulse for 8 months. The performance gain was measured/quantified by bicycle stress tests at the beginning and end of the observation period. sRAGE was measured at baseline and after 2/6/8 months by ELISA. Backwards, multiple linear regression analysis was performed to investigate the association of co-variables age, sex, BMI, and performance at baseline, HbA1c, and lipoprotein a with baseline sRAGE levels. We identified BMI and lipoprotein a as significant predictors for baseline sRAGE levels. Compared to subjects with a performance gain ≤ 4.9% subjects with a gain > 5% showed a significant increase in sRAGE levels up to 22%. sRAGE serum levels correlate negatively with lipoprotein a levels and BMI and long-term physical activity leads to a significant increase in serum sRAGE levels (9-22%), whereby the sRAGE increase is most pronounced in subjects with initially low-performance levels, suggesting that in particular, these subject profit the most from increased physical activity. The sport-mediated increase of sRAGE might be a sign of decreased AGE-mediated inflammation and highlight the protective effect of sports on CVD and other disease which are at least partly mediated by an increased inflammation status.Clinical trials registration NCT02097199.

Keywords: Advanced glycation end products; Inflammation; Physical activity; RAGE; sRAGE.

Conflict of interest statement

The authors have no conflict of interest.

References

    1. Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res. 2004;53(2):131–142.
    1. Shuvaev VV, Laffont I, Serot JM, Fujii J, Taniguchi N, Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer’s disease. Neurobiol Aging. 2001;22(3):397–402. doi: 10.1016/S0197-4580(00)00253-0.
    1. Zieman S, Kass D. Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail. 2004;10(3):144–149. doi: 10.1111/j.1527-5299.2004.03223.x.
    1. Cai XY, Lu L, Wang YN, Jin C, Zhang RY, Zhang Q, Chen QJ, Shen WF. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury. Atherosclerosis. 2011;217(2):536–542. doi: 10.1016/j.atherosclerosis.2011.05.023.
    1. Selvin E, Halushka MK, Rawlings AM, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC. sRAGE and risk of diabetes, cardiovascular disease, and death. Diabetes. 2013;62(6):2116–2121. doi: 10.2337/db12-1528.
    1. Momma H, Niu K, Kobayashi Y, Huang C, Chujo M, Otomo A, Tadaura H, Miyata T, Nagatomi R. Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study. Diabetol Metab Syndr. 2014;6(1):33. doi: 10.1186/1758-5996-6-33.
    1. Lazo M, Halushka MK, Shen L, Maruthur N, Rebholz CM, Rawlings AM, Hoogeveen RC, Brinkley TE, Ballantyne CM, Astor BC, Selvin E. Soluble receptor for advanced glycation end products and the risk for incident heart failure: the Atherosclerosis Risk in Communities study. Am Heart J. 2015;170(5):961–967. doi: 10.1016/j.ahj.2015.08.008.
    1. Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J. Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease. Heart Vessels. 2016;31(10):1603–1608. doi: 10.1007/s00380-015-0778-6.
    1. Sponder M, Campean IA, Emich M, Fritzer-Szekeres M, Litschauer B, Bergler-Klein J, Graf S, Strametz-Juranek J. Long-term endurance training increases serum cathepsin S and decreases IL-6 and hsCRP levels. J Sports Sci. 2017;35(21):2129–2134. doi: 10.1080/02640414.2016.1258482.
    1. Sponder M, Campean IA, Dalos D, Emich M, Fritzer-Szekeres M, Litschauer B, Bergler-Klein J, Graf S, Strametz-Juranek J. Influence of long-term physical activity on PCSK9, HDL/LDL-C and Lp(a)—a prospective observational trial. Pol Arch Intern Med. 2017;127(7–8):506–511.
    1. Sponder M, Kopecky C, Campean IA, Emich M, Fritzer-Szekeres M, Litschauer B, Graf S, Saemann MD, Strametz-Juranek J. Sports and HDL-quality reflected by serum amyloid A and surfactant protein B. Int J Med Sci. 2017;14(11):1040–1048. doi: 10.7150/ijms.20388.
    1. Kotani K, Caccavello R, Sakane N, Yamada T, Taniguchi N, Gugliucci A. Influence of physical activity intervention on circulating soluble receptor for advanced glycation end products in elderly subjects. J Clin Med Res. 2011;3(5):252–257.
    1. Choi KM, Han KA, Ahn HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Yoo HJ, Baik SH, Choi DS, Min KW. Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial. J Clin Endocrinol Metab. 2012;97(10):3751–3758. doi: 10.1210/jc.2012-1951.
    1. Harriss DJ, Atkinson G. Ethical standards in sport and exercise science research: 2016 update. Int J Sports Med. 2015;36(14):1121–1124. doi: 10.1055/s-0035-1565186.
    1. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition. 1989;5(5):303–311.
    1. Luevano-Contreras C, Chapman-Novakofski K. Dietary advanced glycation end products and aging. Nutrients. 2010;2(12):1247–1265. doi: 10.3390/nu2121247.
    1. Bengmark S. Impact of nutrition on ageing and disease. Curr Opin Clin Nutr Metab Care. 2006;9(1):2–7. doi: 10.1097/01.mco.0000171129.29278.26.
    1. Basta G, Lazzerini G, Del Turco S, Ratto GM, Schmidt AM, De Caterina R. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol. 2005;25(7):1401–1407. doi: 10.1161/01.ATV.0000167522.48370.5e.
    1. Prasad K. Low levels of serum soluble receptors for advanced glycation end products, biomarkers for disease state: myth or reality. Int J Angiol. 2014;23(1):11–16. doi: 10.1055/s-0033-1363423.
    1. Raposeiras-Roubin S, Rodino-Janeiro BK, Paradela-Dobarro B, Grigorian-Shamagian L, Garcia-Acuna JM, Aguiar-Souto P, Jacquet-Hervet M, Reino-Maceiras MV, Gonzalez-Juanatey JR, Alvarez E. Fluorescent advanced glycation end products and their soluble receptor: the birth of new plasmatic biomarkers for risk stratification of acute coronary syndrome. PLoS ONE. 2013;8(9):e74302. doi: 10.1371/journal.pone.0074302.
    1. Jensen LJ, Flyvbjerg A, Bjerre M. Soluble receptor for advanced glycation end product: a biomarker for acute coronary syndrome. Biomed Res Int. 2015;2015:815942.
    1. Al Rifai M, Schneider AL, Alonso A, Maruthur N, Parrinello CM, Astor BC, Hoogeveen RC, Soliman EZ, Chen LY, Ballantyne CM, Halushka MK, Selvin E. sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. J Diabetes Complicat. 2015;29(2):180–185. doi: 10.1016/j.jdiacomp.2014.11.008.
    1. Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 2011;20(7):1430–1438. doi: 10.1158/1055-9965.EPI-11-0066.
    1. Jiao L, Weinstein SJ, Albanes D, Taylor PR, Graubard BI, Virtamo J, Stolzenberg-Solomon RZ. Evidence that serum levels of the soluble receptor for advanced glycation end products are inversely associated with pancreatic cancer risk: a prospective study. Cancer Res. 2011;71(10):3582–3589. doi: 10.1158/0008-5472.CAN-10-2573.
    1. Goon JA, Aini AH, Musalmah M, Anum MY, Nazaimoon WM, Ngah WZ. Effect of Tai Chi exercise on DNA damage, antioxidant enzymes, and oxidative stress in middle-age adults. J Phys Act Health. 2009;6(1):43–54. doi: 10.1123/jpah.6.1.43.
    1. Danzig V, Mikova B, Kuchynka P, Benakova H, Zima T, Kittnar O, Skrha J, Linhart A, Kalousova M. Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res. 2010;59(3):385–392.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj